IL10 and neoplasm: Moreover, considering the aforementioned immunomodulatory potential of nanoconjugate, we assumed that the changes in the anti-tumor immune response that occurred after the use of HES-MTX will be crucial for the activation of an effective and specific immune response generated by DCs with decreased sensitivity to the negative impact of the IL-10.